Using Wearable Device to Improve Quality of Palliative Care
Using Wearable Device and Smart Phone to Improve Survival Prediction and Quality of Life in Patients Receiving Palliative Care
1 other identifier
observational
75
1 country
2
Brief Summary
This study is going to use wearable devices and smartphones to collect physical data from terminal patients and build a survival predicting model for terminal patients with machine learning. Investigators hypothesize that continuous physical data monitoring could offer a hint to better predictability in end-of-life care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2021
CompletedStudy Start
First participant enrolled
September 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedNovember 9, 2022
November 1, 2022
1.3 years
August 30, 2021
November 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Area Under the Receiver Operating Characteristic curve (AUC-ROC) of the machine-learning model to predict survival using wearable device parameters and clinical assessment
Measured data from wearable device and regular assessment (including medical condition, laboratory data, symptom, functional assessment) will be integrated to build one machine-learning model to predict patients' death or survival within specific time range. The primary outcome is to evaluate the Area Under the Receiver Operating Characteristic curve (AUC - ROC) of the machine-learning model in predicting patients' survival.
From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Other clinical assessments are performed every week. Death or survival is recorded at the time the case closed.
Area Under the Receiver Operating Characteristic curve (AUC-ROC) of machine-learning model to predict unexpected medical needs using wearable device parameters and clinical assessment
Measured data from wearable device and regular assessment (including medical condition, laboratory data, symptom, functional assessment) will be integrated to build one machine-learning model to predict patient's unexpected medical needs (which is defined as emergency department visit or unplanned admission to hospital). The primary outcome is to evaluate Area Under the Receiver Operating Characteristic curve (AUC-ROC) of the machine-learning model in predicting unexpected medical needs.
From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Other clinical assessments are performed every week. Events are recorded upon happening or afterwards.
Secondary Outcomes (3)
Correlation between symptoms and wearable device parameters
From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Symptoms assessed every week.
Correlation between Australia-modified Karnofsky Performance Status (AKPS) and wearable device parameters
From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Functional status assessed every week.
Correlation between palliative care phase and wearable device parameters
From date of enrollment until the date of death, or assessed up to 26 weeks. Wearable device parameters are collected continuously. Palliative care phase assessed every week.
Other Outcomes (10)
Comparison of AUC-ROC in survival prediction between machine learning model and Palliative Performance Scale (PPS)
From date of enrollment until the date of death, or assessed up to 26 weeks. PPS are assessed every week. Death or survival is recorded at the time the case closed.
Comparison of AUC-ROC in survival prediction between machine learning model and Glasgow Prognostic Score (GPS)
GPS assessed retrospectively if data available. Death or survival is recorded at the time the case closed.
Comparison of AUC-ROC in survival prediction between machine learning model and Palliative Prognostic Index (PPI)
From date of enrollment until the date of death, or assessed up to 26 weeks. PPI are assessed every week. Death or survival is recorded at the time the case closed.
- +7 more other outcomes
Study Arms (1)
Wearable devices + Smartphone
The only arm in the study.
Eligibility Criteria
Terminal cancer patients are receiving palliative care in outpatient clinic, home care or ward admission and will receive regular follow-up in the future.
You may qualify if:
- Age: 20 years old or older
- Clinical diagnosis: cancer in terminal stage.
You may not qualify if:
- \- Cannot cooperate with use of wearable devices or smartphones.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Taiwan University Hospitallead
- National Taiwan Universitycollaborator
Study Sites (2)
National Taiwan University Hospital
Taipei, 100, Taiwan
National Taiwan University, Cancer Center
Taipei, 106, Taiwan
Related Publications (2)
Pavic M, Klaas V, Theile G, Kraft J, Troster G, Blum D, Guckenberger M. Mobile Health Technologies for Continuous Monitoring of Cancer Patients in Palliative Care Aiming to Predict Health Status Deterioration: A Feasibility Study. J Palliat Med. 2020 May;23(5):678-685. doi: 10.1089/jpm.2019.0342. Epub 2019 Dec 23.
PMID: 31873052BACKGROUNDLiu JH, Shih CY, Huang HL, Peng JK, Cheng SY, Tsai JS, Lai F. Evaluating the Potential of Machine Learning and Wearable Devices in End-of-Life Care in Predicting 7-Day Death Events Among Patients With Terminal Cancer: Cohort Study. J Med Internet Res. 2023 Aug 18;25:e47366. doi: 10.2196/47366.
PMID: 37594793DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jaw-Shiun Tsai, MDPHD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2021
First Posted
September 23, 2021
Study Start
September 23, 2021
Primary Completion
December 31, 2022
Study Completion
April 30, 2023
Last Updated
November 9, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share